Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal of Bacteriology
|
July 3, 2007
Identification of a biosynthetic gene cluster and the six associated lipopeptides involved in swarming motility of Pseudomonas syringae pv. tomato DC3000
Andrew D Berti, Nathan J Greve, Quin H Christensen, et al.
Antimicrobial Agents and Chemotherapy
|
July 31, 2013
β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus
Andrew D Berti, George Sakoulas, Victor Nizet, et al.
Applied and Environmental Microbiology
|
May 15, 2007
Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycin
Elizabeth A Felnagle, Michelle R Rondon, Andrew D Berti, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 20, 2015
Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion
Andrew D Berti, Paul R Hutson, Lucas T Schulz, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2012
Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics
Andrew D Berti, Justine E Wergin, Gary G Girdaukas, et al.
Antimicrobial Agents and Chemotherapy
|
November 22, 2017
Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus
Xuting Zheng, Andrew D Berti, Sue McCrone, et al.
Journal of Medical Microbiology
|
September 17, 2025
Rapid deprotection and purification of ceftaroline free base from its phosphoramidate prodrug
Souvik Roy, Robert D Kina, Nathaniel N Koloian, et al.
Antimicrobial Agents and Chemotherapy
|
March 4, 2015
Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics
Andrew D Berti, Sarah L Baines, Benjamin P Howden, et al.
Antimicrobial Agents and Chemotherapy
|
August 8, 2012
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity
Warren E Rose, Lucas T Schulz, David Andes, et al.
Antimicrobial Agents and Chemotherapy
|
January 18, 2022
Proteomic Correlates of Enhanced Daptomycin Activity following β-Lactam Preconditioning in Daptomycin-Resistant, Methicillin-Resistant Staphylococcus aureus
Cassandra Lew, Molly Pellitteri Hahn, Cameron Scarlett, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal of Bacteriology
|
July 3, 2007
Identification of a biosynthetic gene cluster and the six associated lipopeptides involved in swarming motility of Pseudomonas syringae pv. tomato DC3000
Andrew D Berti, Nathan J Greve, Quin H Christensen, et al.
Antimicrobial Agents and Chemotherapy
|
July 31, 2013
β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus
Andrew D Berti, George Sakoulas, Victor Nizet, et al.
Applied and Environmental Microbiology
|
May 15, 2007
Identification of the biosynthetic gene cluster and an additional gene for resistance to the antituberculosis drug capreomycin
Elizabeth A Felnagle, Michelle R Rondon, Andrew D Berti, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 20, 2015
Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion
Andrew D Berti, Paul R Hutson, Lucas T Schulz, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2012
Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics
Andrew D Berti, Justine E Wergin, Gary G Girdaukas, et al.
Antimicrobial Agents and Chemotherapy
|
November 22, 2017
Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus
Xuting Zheng, Andrew D Berti, Sue McCrone, et al.
Journal of Medical Microbiology
|
September 17, 2025
Rapid deprotection and purification of ceftaroline free base from its phosphoramidate prodrug
Souvik Roy, Robert D Kina, Nathaniel N Koloian, et al.
Antimicrobial Agents and Chemotherapy
|
March 4, 2015
Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics
Andrew D Berti, Sarah L Baines, Benjamin P Howden, et al.
Antimicrobial Agents and Chemotherapy
|
August 8, 2012
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity
Warren E Rose, Lucas T Schulz, David Andes, et al.
Antimicrobial Agents and Chemotherapy
|
January 18, 2022
Proteomic Correlates of Enhanced Daptomycin Activity following β-Lactam Preconditioning in Daptomycin-Resistant, Methicillin-Resistant Staphylococcus aureus
Cassandra Lew, Molly Pellitteri Hahn, Cameron Scarlett, et al.
Page
of 4